SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
Han AX, Toporowski A, Sacks JA, Perkins MD, Briand S, van Kerkhove M, Hannay E, Carmona S, Rodriguez B, Parker E, Nichols BE, Russell CA.
Han AX, et al. Among authors: hannay e.
Nat Genet. 2023 Jan;55(1):26-33. doi: 10.1038/s41588-022-01267-w. Epub 2023 Jan 9.
Nat Genet. 2023.
PMID: 36624344
Free PMC article.